Skip to main content
Top
Published in: Journal of Translational Medicine 1/2014

Open Access 01-12-2014 | Research

Biomarkers of early sepsis may be correlated with outcome

Authors: Tsai-Hsia Hong, Chin-Hao Chang, Wen-Je Ko, Ching-Feng Lin, Heng-Hsiu Liu, Lu-Ping Chow, Chun-Ta Huang, Sun-Liang Yu, Yih-Sharng Chen

Published in: Journal of Translational Medicine | Issue 1/2014

Login to get access

Abstract

Background

Sepsis causes high mortality, and the mortality due to secondary infections is even higher. No studies to date have investigated the time from the primary infection to death due to a secondary infection; similarly, the factors that are significantly different in sepsis survivors relative to non-survivors or in severe sepsis patients who suffered a late death relative to those who recover have not been explored. We hypothesized that patients who survive sepsis have a weaker pro-inflammatory response than those who do not and that the mid-term survivors (which acquire secondary infections) would have a pronounced anti-inflammatory response (making them susceptible to infection); this hypothesis was verified in this study.

Methods

We examined 24 patients with severe sepsis; the patients were subdivided by outcome into early death (n = 5), mid-term survival (survival through severe sepsis but death within six months or continued hospitalization for six months, n = 6), and long-term survival (recovery and survival for more than six months, n = 13) groups. The levels of CD3+, CD4+, CD8+, and CD19+ lymphocytes were analyzed by flow cytometry, and the plasma levels of carbonic anhydrase IX (CA IX), MCP-1, IL-6, IL-7, IL-8, and IL-10 were measured by ELISA on days 0, 1, 2, and 3. A statistical comparison of the variables in the groups was conducted using a mixed model.

Results

The plasma levels of MCP-1, IL-6, and IL-8 in early death and survivors were significantly different, and all had p values <0.01. The plasma levels of MCP-1, IL-6, and IL-8 were also significantly different in mid-term survivors and long-term survivors, with p values of <0.01, 0.04, and <0.01, respectively.

Conclusions

Our data support the hypothesis that survivors have a weaker pro-inflammatory response than non-survivors, but the mid-term survivors did not have a more pronounced anti-inflammatory response. The levels of pro-inflammatory cytokines in the mid-term and long-term survivors were significantly different.
Appendix
Available only for authorised users
Literature
1.
go back to reference Suffredini AF, Munford RS: Novel therapies for septic shock over the past 4 decades. JAMA. 2011, 306: 194-199.CrossRefPubMed Suffredini AF, Munford RS: Novel therapies for septic shock over the past 4 decades. JAMA. 2011, 306: 194-199.CrossRefPubMed
2.
go back to reference Angus DC: The search for effective therapy for sepsis back to the drawing board?. JAMA. 2011, 306: 2614-2615. 10.1001/jama.2011.1853.CrossRefPubMed Angus DC: The search for effective therapy for sepsis back to the drawing board?. JAMA. 2011, 306: 2614-2615. 10.1001/jama.2011.1853.CrossRefPubMed
3.
go back to reference Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003, 348: 1546-1554. 10.1056/NEJMoa022139.CrossRefPubMed Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003, 348: 1546-1554. 10.1056/NEJMoa022139.CrossRefPubMed
4.
go back to reference Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002.CrossRefPubMed Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002.CrossRefPubMed
5.
go back to reference Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D, Sepsis Occurrence in Acutely III Patients Investigators: Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006, 34: 344-353. 10.1097/01.CCM.0000194725.48928.3A.CrossRefPubMed Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D, Sepsis Occurrence in Acutely III Patients Investigators: Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006, 34: 344-353. 10.1097/01.CCM.0000194725.48928.3A.CrossRefPubMed
6.
go back to reference Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med. 2003, 348: 138-150. 10.1056/NEJMra021333.CrossRefPubMed Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med. 2003, 348: 138-150. 10.1056/NEJMra021333.CrossRefPubMed
7.
go back to reference Ward NS, Casserly B, Ayala A: The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med. 2008, 29: 617-625. 10.1016/j.ccm.2008.06.010.PubMedCentralCrossRefPubMed Ward NS, Casserly B, Ayala A: The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med. 2008, 29: 617-625. 10.1016/j.ccm.2008.06.010.PubMedCentralCrossRefPubMed
8.
go back to reference Hotchkiss RS, Swanson PE, Cobb JP, Jacobson A, Buchman TG, Karl IE: Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit Care Med. 1997, 25: 1298-1307. 10.1097/00003246-199708000-00015.CrossRefPubMed Hotchkiss RS, Swanson PE, Cobb JP, Jacobson A, Buchman TG, Karl IE: Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit Care Med. 1997, 25: 1298-1307. 10.1097/00003246-199708000-00015.CrossRefPubMed
9.
go back to reference Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T: Fox3+CD25+CD4+ natural T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006, 212: 8-27. 10.1111/j.0105-2896.2006.00427.x.CrossRefPubMed Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T: Fox3+CD25+CD4+ natural T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006, 212: 8-27. 10.1111/j.0105-2896.2006.00427.x.CrossRefPubMed
10.
go back to reference Blumenstein M, Boekstegers P, Fraunberger P, Andreesen R, Xiegler-Heitbrock HW, Fingerle-Rowson G: Cytokine production precedes the expansion of CD14+CD16+ monocytes in human sepsis: a case report of a patient with self-induced septicemia. Shock. 1997, 8: 73-75. 10.1097/00024382-199707000-00012.CrossRefPubMed Blumenstein M, Boekstegers P, Fraunberger P, Andreesen R, Xiegler-Heitbrock HW, Fingerle-Rowson G: Cytokine production precedes the expansion of CD14+CD16+ monocytes in human sepsis: a case report of a patient with self-induced septicemia. Shock. 1997, 8: 73-75. 10.1097/00024382-199707000-00012.CrossRefPubMed
11.
go back to reference Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT: Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care. 2007, 11: R49-10.1186/cc5783.PubMedCentralCrossRefPubMed Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT: Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care. 2007, 11: R49-10.1186/cc5783.PubMedCentralCrossRefPubMed
12.
go back to reference Eckert AW, Kappler M, Schubert J, Taubert H: Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients. Oral Maxillofac Surg. 2012, 16: 189-196. 10.1007/s10006-012-0335-8.CrossRefPubMed Eckert AW, Kappler M, Schubert J, Taubert H: Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients. Oral Maxillofac Surg. 2012, 16: 189-196. 10.1007/s10006-012-0335-8.CrossRefPubMed
13.
go back to reference Wolfinger R, Chang M: Comparing the SAS GLM and MIXED Procedures for Repeated Measures. In Proceedings of the Twentieth Annual SAS Users Group Conference. 1995, Cary, NC: SAS Institute Inc Wolfinger R, Chang M: Comparing the SAS GLM and MIXED Procedures for Repeated Measures. In Proceedings of the Twentieth Annual SAS Users Group Conference. 1995, Cary, NC: SAS Institute Inc
14.
go back to reference Shubin NJ, Monaghan SF, Ayala A: Anti-inflammatory mechanisms of sepsis. Contrib Microbiol. 2011, 17: 108-124.CrossRefPubMed Shubin NJ, Monaghan SF, Ayala A: Anti-inflammatory mechanisms of sepsis. Contrib Microbiol. 2011, 17: 108-124.CrossRefPubMed
15.
go back to reference Aziz M, Jacob A, Yang WL, Matsuda A, Wang P: Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol. 2013, 93: 329-342. 10.1189/jlb.0912437.PubMedCentralCrossRefPubMed Aziz M, Jacob A, Yang WL, Matsuda A, Wang P: Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol. 2013, 93: 329-342. 10.1189/jlb.0912437.PubMedCentralCrossRefPubMed
16.
go back to reference Hoser GA, Skirecki T, Zlotorowicz M, Zielińska-Borkowska U, Kawiak J: Absolute counts of peripheral blood leukocyte subpopulations in intraabdominal sepsis and pneumonia-derived sepsis: a pilot study. Folia Histochem Cytobiol. 2012, 50: 420-426. 10.5603/FHC.2012.0057.CrossRefPubMed Hoser GA, Skirecki T, Zlotorowicz M, Zielińska-Borkowska U, Kawiak J: Absolute counts of peripheral blood leukocyte subpopulations in intraabdominal sepsis and pneumonia-derived sepsis: a pilot study. Folia Histochem Cytobiol. 2012, 50: 420-426. 10.5603/FHC.2012.0057.CrossRefPubMed
17.
go back to reference Chen X, Ye J, Ye J: Analysis of peripheral blood lymphocyte subsets and prognosis in patients with septic shock. Microbiol Immunol. 2011, 55: 736-742. 10.1111/j.1348-0421.2011.00373.x.CrossRefPubMed Chen X, Ye J, Ye J: Analysis of peripheral blood lymphocyte subsets and prognosis in patients with septic shock. Microbiol Immunol. 2011, 55: 736-742. 10.1111/j.1348-0421.2011.00373.x.CrossRefPubMed
Metadata
Title
Biomarkers of early sepsis may be correlated with outcome
Authors
Tsai-Hsia Hong
Chin-Hao Chang
Wen-Je Ko
Ching-Feng Lin
Heng-Hsiu Liu
Lu-Ping Chow
Chun-Ta Huang
Sun-Liang Yu
Yih-Sharng Chen
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2014
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-12-146

Other articles of this Issue 1/2014

Journal of Translational Medicine 1/2014 Go to the issue